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Cellular signal transduction pathways are usually studied following administration of an external
stimulus. However, disease-associated aberrant activity of the pathway is often due to misregulation
of the equilibrium state. The transcription factor NF-jB is typically described as being held inactive
in the cytoplasm by binding its inhibitor, IjB, until an external stimulus triggers IjB degradation
through an IjB kinase-dependent degradation pathway. Combining genetic, biochemical, and
computational tools, we investigate steady-state regulation of the NF-jB signaling module and its
impact on stimulus responsiveness. We present newly measured in vivo degradation rate constants
for NF-jB-bound and -unbound IjB proteins that are critical for accurate computational predictions
of steady-state IjB protein levels and basal NF-jB activity. Simulations reveal a homeostatic NF-jB
signaling module in which differential degradation rates of free and bound pools of IjB represent a
novel cross-regulation mechanism that imparts functional robustness to the signaling module.
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Introduction
Cellular signal transduction pathways mediate responses to
extracellular and intracellular signals, such as changing
environmental and metabolic conditions, pathogen assault,
and developmental cues. Many signaling pathways control the
activity of transcription factors that regulate cognate target
genes (Brivanlou and Darnell, 2002). For immediate early
transcriptional responses (not requiring induced synthesis),
such regulation may involve the reversible phosphorylation of
the transcription factor to induce dimerization or nuclear
translocation (e.g. the Stat, IRF, AP-1 transcription factor
families). An alternate means of pathway activation involves
stabilization of the transcriptional effector, as in the case of the
genotoxic response regulator p53, the hypoxia response factor
HIF-1a, or the developmentally regulated coactivator b-
catenin. Thus, signaling in response to stimulus involves
alterations of the homeostatic rates of synthesis and degrada-
tion found in unstimulated cells.
In contrast, the cellular abundance of the transcription
factor NF-kB does not change dramatically during signaling.
NF-kB is the critical mediator of cellular responses to a large
number of physiological stimuli, including inflammatory
cytokines, developmental signals, pathogens, and cellular
stresses (Figure 1A) (Hoffmann and Baltimore, 2006).
Although inflammatory signaling leads to transient NF-kB
activity that is dynamically regulated by feedback mechan-
isms, elevated constitutive levels of active NF-kB are
associated with chronic inflammatory diseases and many
types of cancer (Karin, 2006).
NF-kB activity is inhibited by association with the inhibitor
proteins, IkBa, IkBb, or IkBe, which mask its nuclear
localization sequence and inhibit its DNA-binding activity.
The regulated metabolism of IkB proteins—their synthesis and
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degradation—critically controls NF-kB signaling (Ghosh et al,
1998). Synthesis of IkB proteins is a highly regulated process,
with at least two isoforms, IkBa and IkBe, being subject to
NF-kB-inducible synthesis, thereby providing negative feed-
back (Scott et al, 1993; Kearns et al, 2006). Stimulus-induced
IkB degradation is controlled by the IkB kinase (IKK), which
phosphorylates two N-terminal serines. This leads to IkB
polyubiquitination and degradation via the 26S proteasome,
thus liberating NF-kB for nuclear translocation (Ghosh et al,
1998; Yaron et al, 1998).
These processes were described in a mathematical model
of the IKK-IkB-NF-kB signaling module to recapitulate NF-kB
activation in response to TNF stimulation (Hoffmann et al,
2002). Its construction relied on rate constants available in the
literature from a diverse set of experiments. As no isoform-
specific data were available, rate constants pertaining to IkBb
and IkBe were assumed to be the same as those measured for
IkBa. Although this model accurately recapitulates NF-kB
signaling in response to TNF, in the unstimulated state the
estimated IkB levels were found to be unexpectedly high
(Lipniacki et al, 2004). In fact, the vast majority of IkB were
calculated to be in the free form, contradictory to experimental
studies showing that free IkBa accounts for less than 15% of
the total cellular IkB (Rice and Ernst, 1993).
Despite our detailed understanding of stimulus-induced NF-
kB signaling, there is less clarity about the mechanisms
mediating IkB turnover in the absence of external stimulation.
Early studies reported that basal turnover of IkB, unlike its
induced degradation, does not require the IKK-targeted
serines, the C-terminal PEST domain, or poly-ubiquitination
of IkB (Krappmann et al, 1996), whereas others found robust
C-terminal phosphorylation and poly-ubiquitination (Pando
and Verma, 2000).
By distinguishing between NF-kB-bound and free IkB pools
using an IkB interaction mutant, the half-life of bound IkB
was found to be five-fold longer than that of free IkB in
unstimulated cells (Pando and Verma, 2000). However, free
IkB is a poorer substrate for IKK than NF-kB-bound IkB (Zandi
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Figure 1 Exploring the relative importance of IkB degradation mechanisms by computational parameter sensitivity analysis. (A) Schematic of the NF-kB signaling
module and its physiological importance in the transduction of diverse inflammatory, developmental, and stress signals. (B) Illustration of the four IkB degradation
pathways within the NF-kB signaling module. deg1 and deg4 are IKK-independent degradation rate constants for free and bound IkBa. r1 and r4 are IKK-dependent
degradation rate constants for free and bound IkBa. (C) Computational simulation of NF-kB activation over a 6-h time course. TNF stimulation begins at time 0, and is
removed at 4 h. Mean activity in the first hour of stimulation and the second hour after removal of the stimulus (shaded in gray) were used to create the plots in (D–F) and
(G). (D–G) Graphs showing the average nuclear NF-kB (y axis) during the first hour (D, F) or during the second hour after 4 h (E, G) of TNF stimulation for different
values (x axis) of the IKK-dependent (D, E) or -independent (F, G) degradation rate constants of free (blue line) and bound (red line) IkB.
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et al, 1998), although it is routinely used as a substrate to
measure IKK activity in vitro. Free IkB turnover was proposed
to involve casein kinase 2 (CK2)-mediated phosphorylation
of the C-terminal domain and ubiquitination (Schwarz et al,
1996; Bren et al, 2000), but others suggested that CK2 is
involved in inducible degradation of NF-kB-bound IkB (Kato
et al, 2003), or that ubiquitination was not required
(Krappmann et al, 1996; Alvarez-Castelao and Castano, 2005).
Given these contradictory results in the literature, the lack of
data on two of the three IkB isoforms, and the poor fit of
computational simulations of the NF-kB signaling module in
cells not exposed to TNF, we generated genetic tools—mouse
knockout cell lines—to isolate cleanly the endogenous-free
and -bound IkB protein pools and probe their degradation with
kinase knockouts and pharmacological inhibitors. In addition,
we used computational modeling (i) to identify which
constitutive degradation rate constants play a critical role in
determining stimulus responsiveness, (ii) to determine new
biochemical rate constants based on our experimental results,
(iii) to confirm the validity of the new parameters by
simulating the cellular steady state, and (iv) to reveal the
control of IkB degradation by NF-kB as a cross-regulatory
mechanism.
Results and discussion
IKK-dependent and -independent degradation of
IjBs determine NF-jB signaling
Four degradation rate constants govern the in vivo half-life of
IkB proteins (Figure 1B). An IkB molecule can exist in either
the free or NF-kB-bound form. Both forms may be degraded in
an IKK-dependent manner (we denote the IkBa rate constants
of these processes r1 and r4, respectively), but are also subject
to constitutive degradation in an IKK-independent manner
(with the rate constants denoted as deg1 and deg4). These
mechanisms are described as first-order rate constants in our
mathematical model of NF-kB signaling (Hoffmann et al,
2002).
To explore the functional significance of each IkB degrada-
tion rate constant in NF-kB signal transduction, we performed
simulations of TNF signaling after altering one of the four rate
constants (simultaneously for the IkBa, b, and e isoforms) with
a parameter multiplier ranging from 0.01 to 100. For each
parameter multiplier, we calculated the average nuclear NF-kB
level in response to TNF during the early phase (during the
first hour of stimulation) and the later attenuation phase
(during the second hour after a 4 h stimulation) (Figure 1C). By
plotting the calculated NF-kB activity against its parameter
multiplier, we can interpret the sensitivity of the system to
each rate constant for two critical features of the NF-kB
response to a transient TNF stimulus: activation and attenua-
tion of NF-kB activity.
We first examined the impact of changes in IKK-dependent
IkB degradation rate constants on NF-kB activation. During the
first hour of TNF stimulation, the amount of nuclear NF-kB
calculated by the model is fairly insensitive to even drastic
changes in the IKK-dependent degradation rate of free IkB
(Figure 1D, blue line). In contrast, slowing down the IKK-
induced degradation of NF-kB-bound IkB severely dampens
NF-kB activity (Figure 1D, red line). During the attenuation
phase, the amount of nuclear NF-kB predicted by the model
was similarly found to be insensitive to changes in IKK-
dependent degradation of free IkB (Figure 1E, blue line), but
slowing the IKK-dependent degradation rate of bound IkB
results in a loss of attenuation (Figure 1E, red line).
The IKK-independent IkB degradation rates control the
stimulus-independent turnover of IkB proteins, and thus
maintain a resting state equilibrium of IkB levels. Examining
whether these IKK-independent degradation rates play a role
in determining the cellular responsiveness to inflammatory
stimuli revealed that during the first hour of TNF stimulation
the signaling module is dramatically more sensitive to the
basal turnover rate of free IkB (Figure 1F, blue line) than of
bound IkB (Figure 1F, red line). Furthermore, our simulations
predicted that a more stable free IkB results in a loss of
attenuation, whereas the basal turnover rate of the bound IkBs
had no effect (Figure 1G).
In sum, our computational simulations revealed that two of
the four possible degradation pathways play a particularly
important role in controlling NF-kB signaling. Whereas much
is known about the stimulus-responsive IKK-mediated degra-
dation pathway, the IKK-independent degradation mechanism
of free IkB has received surprisingly little experimental
attention. Given the importance of these degradation rate
constants in our computational analysis, we set out to examine
them in more detail experimentally.
NF-jB regulation of IjB protein turnover and
synthesis
To measure experimentally in vivo degradation rate constants
for NF-kB-bound IkB proteins, we used the ribosomal inhibitor
cycloheximide (CHX) to reduce the synthesis of new IkB
proteins (by 85%; Supplementary Figure S1A), and examined
the amount of nuclear NF-kB DNA-binding activity via
electrophoretic mobility shift assay (EMSA). Treatment of
wild-type MEFs with CHX over a 60 h time course induced
nuclear NF-kB activity that corresponds to 25–35% of peak
TNF-induced NF-kB activity (Figure 2A, Supplementary Figure
S1B). To determine the relative contributions of each NF-kB-
bound IkB isoform (a, b, and e) to CHX-mediated NF-kB
activation, we used a panel of IkB double-knockout MEFs,
which contain only one IkB isoform. These cells were
previously used to determine the degradation rate constants
for each IkB isoform by TNF-induced NF-kB activation, which
revealed that upon IKK activation, IkBa was degraded most
rapidly, followed by IkBe, and then IkBb (Hoffmann et al,
2002). Interestingly, we find the same trend in stimulus-
independent degradation, where IkBb is the most stable and
IkBa is the least stable (Figure 2B and Supplementary Figure
S1C).
To investigate the stability of the unbound, or ‘free’, IkB
proteins in resting cells, we generated crel/rela/nfkb1/
(termed ‘nfkb/’) MEFs deficient in the three NF-kB proteins
known to interact with the classical IkB proteins: RelA, c-Rel,
and p50. Western blots revealed a dramatic reduction in the
amount of total IkB protein level in these cells compared to
wild type (Figure 2C, compare lanes 3 and 6). A dilution series
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of wild-type protein extract with ikba/b/e/ extract
showed that the amount of IkBa in the nfkb/ cells was
approximately one-twentieth the amount in wild-type cells,
and that this ratio is probably even lower for IkBb and IkBe
(Supplementary Figure S2A). No decrease in IkB levels was
detected in MEFs deficient in the NF-kB proteins RelB and
nfkb2 p52, which are non-canonical NF-kB proteins that do
not bind canonical IkB proteins.
Strikingly, the level of IkBa mRNA in the nfkb/ cells was
only two-fold lower than in wild type, with even smaller
differences in IkBb and IkBe mRNA levels (Supplementary
Figure S2B), suggesting that differential protein stability may
account for different IkB protein levels in wild-type and nfkb/
cells. Indeed, treating nfkb/ cells with CHX resulted in rapid
decreases of IkBa protein, whereas it remains stable in the
wild-type cells beyond 2 h (Figure 2C). These results suggest
that NF-kB has a regulatory role not only in controlling IkBa
transcription, but also in stabilizing IkB proteins.
We next investigated whether the dramatically different
half-life of free and bound IkB proteins may be due to different
mechanisms governing their degradation.
IKK phosphorylation is a key mediator of the stimulus-
induced degradation of NF-kB-bound IkB proteins, yet it is
unclear if and how IKK may participate in the basal
degradation of bound IkB. We first performed a kinase assay
to examine the IKK activity of immunoprecipitated IKK
complex from wild-type MEFs. Surprisingly, even in resting
cells, a substantial amount of basal activity associated with the
IKK complex was detectable (Figure 2D). In cells lacking the
IKK catalytic subunits, IKKa and IKKb, no activation of NF-kB
upon CHX treatment (Figure 2E) was observed, indicating that
IKK-dependent phosphorylation is required for the basal
turnover of NF-kB-bound IkB proteins.
We sought to determine if IKK activity is involved in the
turnover of free IkB proteins as well. IP-IKK kinase assays
determined that the basal and inducible IKK activities are
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Figure 2 Experimental studies of degradation pathways of NF-kB-bound and -free IkB proteins. (A) NF-kB activity as measured by EMSA of nuclear extracts from wild-type
cells treated with 10 mg/ml CHX or 1 ng/ml TNF for indicated times. (B) NF-kB activity as measured by EMSA of nuclear extracts from ikbb/e/, ikba/e/,
or ikba/b/ cells treated with 10 mg/ml CHX or 1 ng/ml TNF. (C) Western blot for IkBa in CHX-treated wild-type and nfkb/ cells. The first two lanes show
ikba/b/e/ extract and ikba/b/e/ extract mixed with 5% wild-type extract to show the protein level of IkBa in the nfkb/ cells was approximately 5%
that in the wild-type cells at time zero. (D) Cytoplasmic extracts of wild-type cells were immunoprecipitated with IKKg antibody and subject to an in vitro kinase assay. In
the ‘mock’ lane, no antibody was added during the IP. (E) NF-kB activity as measured by EMSA of nuclear extracts from ikka/b/ or wild-type MEFs treated with
10 mg/ml CHX. (F) Western blot for IkBa of protein extracts from TNF (1 ng/ml)-treated wild-type or rela/crel/nfkb1/ cells. (G) Western blots for IkBa of
protein extracts from TNF-treated wild-type cells (top panel) in the presence or absence of the IKK-inhibitor sc-514. Bottom panels show Western blots for IkBa of protein
extracts from CHX (10 mg/ml)-treated cells in the presence or absence of sc-514. (H) Western blots for IkBa of protein extracts from wild-type cells treated with TNFa
(1 ng/ml) with or without the presence of the proteasome inhibitor MG132 (top panel). Western blots for IkBa of protein extracts from nfkb/ cells treated with 10 mg/ml
CHX, 10 mM MG132, or both.
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intact in the nfkb/ cell line (Supplementary Figure S3A).
Treatment of wild-type cells with TNF led to the rapid
degradation of IkBa, but did not affect the levels of IkBa in
the nfkb/ cells (Figure 2F and Supplementary Figure S3B),
suggesting that the inducible IKK activity is not involved in the
degradation of free IkBa. Further, the IKK inhibitor, sc-514,
which diminishes the TNF-induced degradation of IkBa in
wild-type cells, did not have an effect on the basal turnover
of free IkB in nfkb/ cells (Figure 2G). In contrast, the
proteasome inhibitor MG132 prevented not only TNF-induced
degradation of IkBa in wild-type cells, but also led to
accumulation of free IkB in nfkb/ cells, and prevented its
degradation when cells were cotreated with CHX (Figure 2H).
Based on our new biochemical data, we revised the
parameter values governing degradation of IkB proteins within
the NF-kB signaling module and incorporated these into our
mathematical model (now termed model 1.1). Half-lives for
free IkB proteins were determined to be 5–10 min (Figures 2H
and Supplementary Figure S2, allowing us to calculate the
respective first order rate constants (deg1-3). Our data highly
constrained IKK-independent degradation rate constants
(deg4-6) for NF-kB-bound IkB proteins (Figure 2E). While
previous studies suggested that NF-kB stabilized free IkB
degradation by a factor of 5 (Pando and Verma, 2000), our new
measurements (Table I) indicate an NF-kB effect of 2000-fold
with respect to the IKK-independent degradation of IkB
proteins. This large discrepancy likely lies in the facts that (i)
we have used a clean genetic system to isolate free endogenous
IkB from NF-kB proteins, and have thus obtained a much faster
degradation rate for free IkB and (ii) we have determined that
degradation of NF-kB-bound IkB proteins can only occur
through an IKK-involving mechanism and have thus drasti-
cally decreased the IKK-independent degradation rate of
bound IkB.
After incorporation of the new rate constants in Table I, we
performed model fitting as described previously (Hoffmann
et al, 2002) to obtain new degradation rate constants for IKK-
induced degradation of NF-kB-bound IkB proteins (r4-6;
Supplementary Table SI). As IKK-mediated phosphorylation
of IkB is five-fold more efficient when NF-kB is present (Zandi
et al, 1998), we divided the newly determined r4-6 by 5 to
determine IKK-induced degradation of free IkB proteins
(Supplementary Table SI, see Supplementary information for
rate constant derivations). Including eight-fold differential IKK
association rate constants (Zandi et al, 1998), the combined
NF-kB effect on IKK-mediated degradation of free and bound
IkB proteins is almost 50-fold.
Our results emphasize that NF-kB determines the degrada-
tion mechanism of IkB proteins. When bound to NF-kB, IkB
turnover is slow and dependent on the basal activity of IKK. In
contrast, when not bound to NF-kB, IkB degradation is rapid
and independent of IKK activity.
Cross-regulation between IjB proteins via half-life
control by NF-jB
We compared the steady-state levels of IkB predicted for
unstimulated cells by the previous version of the model
(referred to as model 1.0) (Hoffmann et al, 2002) and the new
version of the model that incorporates the new rate constants
of Tables I and Supplementary Table I (model 1.1) (Figure 3A,
white and gray bars, respectively). The new degradation rate
constants result in predictions of a much smaller pool of free
IkB protein, as well as less total cellular IkB protein. The
Table I Rate constants for IKK-independent IkB degradation: a role for NF-kB
Rate constants (s1) NF-kB effect
IkBa
Free deg1:2103 2000
Bound deg4:1106
IkBb
Free deg2:3103 3000
Bound deg5:1106
IkBe
Free deg3:3103 3000
Bound deg6:1106
New rate constants governing the uninduced IKK-independent degradation of
IkB proteins derived from experiments in this paper and used in an updated
version of the mathematical model. The ratio of IkB degradation rate constants
in the presence and absence of NF-kB is defined as the ‘NF-kB effect’.
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Figure 3 An improved model of the homeostatic NF-kB signaling module. (A)
Model calculations of IkBa, b, and e protein levels (nM) in unstimulated cells for
total IkB, free IkB, or NF-kB-bound IkB. Model 1.0 predictions are white bars,
model 1.1 predictions are gray bars. (B) Model calculations of NF-kB activity
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activity in untreated cells as measured by EMSA of nuclear extracts from the
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wild-type cells, ikba/ cells with empty vector control, or ikba/ cells
expressing a retroviral ikba transgene. GAPDH is used as a loading control. (E)
Western blots for IkBe and IkBa in resting cells. The cell genotype is listed above
each lane.
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simulation results produced with the new model (1.1) are
therefore in much better agreement with experimental
observations (Rice and Ernst, 1993) than those with the
previous model. Although a previous study (Lipniacki et al,
2004) lowered the IkB synthesis rate to correct the model-
predicted ratio of free to bound IkB protein in the steady state,
our new data indicate that the rapid free IkB degradation
necessitates a high synthesis rate.
Next, we examined the consequences of the new degrada-
tion parameters on constitutive NF-kB activity in a series of IkB
knockout cell lines. The previous model predicts that the
removal of IkBa results in high levels of nuclear NF-kB activity
in unstimulated cells (Figure 3B), which does not match with
our experimental observations (Figure 3C). The differential
degradation rates of bound and unbound IkB protein may
result in molecular compensation among the IkB isoforms;
upon deletion of a single IkB isoform, the newly available NF-
kB may act to stabilize the remaining IkB isoforms, resulting in
the cytoplasmic retention of NF-kB. Indeed, model 1.1 predicts
a lower level of NF-kB activity in unstimulated knockout cells
than version 1.0 (Figure 3B, compare white and gray bars).
EMSA results (Figure 3C) confirm the new predictions,
indicating that functional IkB compensation via differential
half-life control indeed exists.
In the case of ikba/b/ cells where IkBe is the only
isoform present, our model predicts a markedly higher level of
NF-kB activity than seen experimentally. However, we have
recently characterized an NF-kB-inducible IkBe mRNA synth-
esis mechanism (Kearns et al, 2006). Incorporation of this
feedback mechanism into the model (referred to as model 1.2)
indeed lowers the predicted basal NF-kB levels (Figure 3B,
black bars) to levels that are in good agreement with the EMSA
results. We measured IkBe mRNA levels and found that they
are indeed upregulated in ikba/ cells compared to wild type
(Figure 3D), resulting in higher IkBe protein levels (Figure 3E).
To determine whether this effect was the result of homeostatic
regulation within the NF-kB signaling module, we used a
retroviral transgene to reconstitute IkBa expression in ikba/
cells. Indeed, we found that IkBe upregulation was reversible,
confirming that even in resting cells constitutive NF-kB
activity plays a role in transcriptional regulation of its
inhibitors to controls its own steady-state activity.
Homeostatic control via distinct IjB degradation
pathways
Our analysis of the NF-kB signaling module in unstimulated
cells reveals a highly dynamic homeostatic state that is
controlled by multiple synthesis and degradation mechanisms
of the regulatory IkB proteins. As such we find that NF-kB itself
has two roles in regulating its own basal activity. NF-kB
binding to IkB proteins removes them from this rapid
degradation pathway, and sensitizes them to a slow degrada-
tion mechanism that is dependent on basal IKK activity.
Second, constitutive NF-kB activity also impacts transcription
rates of IkBa and IkBe, thus providing for negative feedback
even in the absence of an external stimulus.
Our studies identify the free IkB protein degradation
pathway as a major determinant of constitutive NF-kB and of
stimulus responsiveness of the NF-kB signaling module. Given
this hitherto unappreciated importance, determining the
enzymatic and potentially regulatory mechanisms of the free
IkB degradation pathway is critical for understanding the
regulation of NF-kB in diverse physiological and pathological
settings.
Owing to the dynamic nature of the IkB-NF-kB equilibrium,
the majority of newly synthesized IkB is likely degraded before
ever binding NF-kB. However, this is not unlike other signal
transduction pathways that consume significant cellular
resources for the maintenance of a dynamic homeostatic state.
For example, the transcription factors p53, HIF-1a, and b-
catenin are continually synthesized and degraded. Upon
signaling, the respective degradation pathways are inhibited
to allow for their nuclear accumulation and function (Ivan
et al, 2001; Jaakkola et al, 2001; Moon, 2005). How may this
energy-consuming process of maintaining a dynamic home-
ostasis benefit the cell? Future computational studies may
suggest that homeostatic control of the NF-kB signaling
module confers sensitivity to signals but ensures a very steady
low equilibrium activity that is less likely to drift (D Barken,
unpublished results). In addition, combined computational
and experimental studies may demonstrate that such a
dynamic equilibrium state sensitizes the signaling pathway
to metabolic changes, such that stress conditions constitute an
input signal that results in cellular responses (Ellen L O’Dea,
unpublished results).
Materials and methods
Cells and reagents
Primary and 3T3 immortalized MEF were generated from E12.5–14.5
embryos and maintained as described previously (Hoffmann et al,
2002). rela/crel/nfkb1/ MEFs were generated from E12.5-timed
matings of relaþ /crel/nfkb1/ mice and ikba/b/e/ cells
will be described elsewhere. ikk1/ikk2/ cells were a kind gift from
Inder Verma. ikba/ MEF lines reconstituted with pBabe-IkBa and
empty vector control were a generous gift from Erika Mathes.
Recombinant murine TNF was from Roche; CHX, sc-514, and MG132
from Sigma. RelA/p65 (sc-372), RelB (sc-226), cRel (sc-71), IkBa
(sc-371), IkBb (sc-946), and IkBe (sc-7156) antibodies were from
Santa Cruz Biotechnology. Trans35S-methionine label was from MP
Biomedicals.
Biochemical analysis
Whole-cell extracts were prepared in RIPA buffer and equivalent
protein amounts subjected to immunoblot analysis using ECL-plus
(Amersham/GE Healthcare). Nuclear extracts were prepared and used
for electrophoretic EMSA as described (Hoffmann et al, 2002).
Immunoprecipitation kinase assay performed as in Werner et al
(2005). Signals were quantified using a phosphorimager (Molecular
Dynamics) and ImageQuant software version 5.2 (GE Healthcare).
Dilution series with knockout extracts assured that Western blot
signals were in the linear range. Total cellular RNA was isolated with
Trizol reagent (Invitrogen) and used for RNase protection assay as
described in Kearns et al (2006).
Cells were labeled with 200 mCi/ml 35S-methionine label for
indicated times. Whole-cell extracts were prepared in RIPA buffer
and dried on filter paper. 35S-Met incorporation was measured by
scintillation count and CHX-treated cells versus untreated cells were
compared to measure the percentage of translational inhibition.
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Computational modeling
The mathematical model of the IKK-IkB-NF-kB signaling module was
described in Hoffmann et al (2002). This model (version 1.0) was used
to generate Figure 1. Model version 1.1 includes the parameter values
shown in Table I and baseline level of IKK of 1 nM. Simulations were
performed in Matlab and Excel as described previously (Hoffmann
et al, 2002) with extended equilibration times. A complete list of the
parameter values can be found in the Supplementary information.
Graphs were generated in Excel. The Matlab code file is available upon
request, and the SBML code is available at the MSB website.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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